Quick Answer
Orthofix Medical Inc. reported Research And Development Expense of $65.85 million for the year ending 2025.
- Orthofix Medical Inc. showed a decrease of -10.6% in Research And Development Expense from 2024 to 2025.
- This data is from Orthofix Medical Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), Orthofix Medical Inc.'s Research And Development Expense has grown by 109.3%.
- Historical annual values: Fiscal year 2025: $65.85 million | Fiscal year 2024: $73.64 million | Fiscal year 2023: $80.23 million | Fiscal year 2022: $49.07 million | Fiscal year 2021: $49.62 million | Fiscal year 2020: $39.06 million | Fiscal year 2019: $34.64 million | Fiscal year 2018: $33.22 million | Fiscal year 2017: $29.70 million | Fiscal year 2016: $28.80 million | Fiscal year 2015: $26.39 million | Fiscal year 2014: $24.99 million | Fiscal year 2013: $26.77 million | Fiscal year 2012: $28.58 million | Fiscal year 2011: $22.86 million | Fiscal year 2010: $27.96 million | Fiscal year 2009: $31.46 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: